Wacker MG - Search Results

1

Nanopharmaceuticals for wound healing - Lost in translation?

Ashtikar M, Wacker MG. Ashtikar M, et al. Among authors: wacker mg. Adv Drug Deliv Rev. 2018 Apr;129:194-218. doi: 10.1016/j.addr.2018.03.005. Epub 2018 Mar 19. Adv Drug Deliv Rev. 2018. PMID: 29567397 Review.

2

Nanotherapeutics--product development along the "nanomaterial" discussion.

Wacker MG. Wacker MG. J Pharm Sci. 2014 Mar;103(3):777-84. doi: 10.1002/jps.23879. Epub 2014 Jan 30. J Pharm Sci. 2014. PMID: 24481705 Review.

3

Optimizing novel implant formulations for the prolonged release of biopharmaceuticals using in vitro and in vivo imaging techniques.

Beyer S, Xie L, Schmidt M, de Bruin N, Ashtikar M, Rüschenbaum S, Lange CM, Vogel V, Mäntele W, Parnham MJ, Wacker MG. Beyer S, et al. Among authors: wacker mg. J Control Release. 2016 Aug 10;235:352-364. doi: 10.1016/j.jconrel.2016.06.013. Epub 2016 Jun 8. J Control Release. 2016. PMID: 27288876

4

Predictive PBPK modeling as a tool in the formulation of the drug candidate TMP-001.

Nothnagel L, Jung F, Rossmanith T, Thurn M, Ashtikar M, Geisslinger G, Parnham MJ, Wacker MG. Nothnagel L, et al. Among authors: wacker mg. Eur J Pharm Biopharm. 2019 Jan;134:144-152. doi: 10.1016/j.ejpb.2018.11.012. Epub 2018 Nov 16. Eur J Pharm Biopharm. 2019. PMID: 30453024

5

Stimulating brain recovery after stroke using theranostic albumin nanocarriers loaded with nerve growth factor in combination therapy.

Feczkó T, Piiper A, Ansar S, Blixt FW, Ashtikar M, Schiffmann S, Ulshöfer T, Parnham MJ, Harel Y, Israel LL, Lellouche JP, Wacker MG. Feczkó T, et al. Among authors: wacker mg. J Control Release. 2019 Jan 10;293:63-72. doi: 10.1016/j.jconrel.2018.11.017. Epub 2018 Nov 17. J Control Release. 2019. PMID: 30458203

6

Nanomedicines - Tiny particles and big challenges.

Marques MRC, Choo Q, Ashtikar M, Rocha TC, Bremer-Hoffmann S, Wacker MG. Marques MRC, et al. Among authors: wacker mg. Adv Drug Deliv Rev. 2019 Nov-Dec;151-152:23-43. doi: 10.1016/j.addr.2019.06.003. Epub 2019 Jun 19. Adv Drug Deliv Rev. 2019. PMID: 31226397 Review.

7

Advanced in silico modeling explains pharmacokinetics and biodistribution of temoporfin nanocrystals in humans.

Jablonka L, Ashtikar M, Gao G, Jung F, Thurn M, Preuß A, Scheglmann D, Albrecht V, Röder B, Wacker MG. Jablonka L, et al. Among authors: wacker mg. J Control Release. 2019 Aug 28;308:57-70. doi: 10.1016/j.jconrel.2019.06.029. Epub 2019 Jun 24. J Control Release. 2019. PMID: 31247282

8

Predicting human pharmacokinetics of liposomal temoporfin using a hybrid in silico model.

Jablonka L, Ashtikar M, Gao GF, Thurn M, Modh H, Wang JW, Preuß A, Scheglmann D, Albrecht V, Röder B, Wacker MG. Jablonka L, et al. Among authors: wacker mg. Eur J Pharm Biopharm. 2020 Apr;149:121-134. doi: 10.1016/j.ejpb.2020.02.001. Epub 2020 Feb 6. Eur J Pharm Biopharm. 2020. PMID: 32035970

9

Predicting drug release and degradation kinetics of long-acting microsphere formulations of tacrolimus for subcutaneous injection.

Gao GF, Ashtikar M, Kojima R, Yoshida T, Kaihara M, Tajiri T, Shanehsazzadeh S, Modh H, Wacker MG. Gao GF, et al. Among authors: wacker mg. J Control Release. 2021 Jan 10;329:372-384. doi: 10.1016/j.jconrel.2020.11.055. Epub 2020 Nov 30. J Control Release. 2021. PMID: 33271202

10

Nanomedicine at the crossroads - A quick guide for IVIVC.

Mast MP, Modh H, Champanhac C, Wang JW, Storm G, Krämer J, Mailänder V, Pastorin G, Wacker MG. Mast MP, et al. Among authors: wacker mg. Adv Drug Deliv Rev. 2021 Dec;179:113829. doi: 10.1016/j.addr.2021.113829. Epub 2021 Jun 24. Adv Drug Deliv Rev. 2021. PMID: 34174332 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page